Predictors of bipolar disorder risk among patients currently treated for major depression

MedGenMed Medscape General Medicine

Volumn 8, Issue 3, 2006, Pages

  Calabrese, Joseph R ^a   Muzina, David J ^b   Kemp, David E ^c   Sachs, Gary S ^d   Frye, Mark A ^e   Thompson, Thomas R ^f   Klingman, David ^g   Reed, Michael L ^h   Hirschfeld, Robert M A ⁱ  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GLAXOSMITHKLINE   (United States)

^g ValueMedics Research LLC   (United States)

^h VEDANTA RESEARCH   (United States)

ⁱ University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; ELECTROCONVULSIVE THERAPY; FAMILY HISTORY; FEMALE; HEALTH STATUS; HUMAN; HUMAN RELATION; LEGAL LIABILITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; PATIENT SELECTION; PREDICTION; PSYCHIATRIST; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SELF REPORT; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; TREATMENT FAILURE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TREATMENT FAILURE;

EID: 33747342458     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry. 2002;181:284-294. Abstract
2. Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry. 2001;62869-877.
3. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry. 2001;178:234-241. Abstract
4. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179-200. Abstract
5. Kennedy N, Paykel ES. Treatment and response in refractory depression: results from a specialist affective disorders service. J Affect Disord. 2004;81:49-53. Abstract
6. Kennedy N, Abbott R, Paykel ES. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med. 2003;33:827-838. Abstract
7. Manning JS. Difficult-to-treat depressions: a primary care perspective. J Clin Psychiatry. 2003;64(suppl 1):24-31. Abstract
8. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53-59.
9. Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001;67:45-59. Abstract
10. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-294. Abstract
11. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161-174. Abstract
12. Hirschfeld RMA. Bipolar spectrum disorder: improving its recognition and diagnosis. J Clin Psychiatry. 2001;62(suppl 14):5-9. Abstract
13. Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract. 2005;18:233-239. Abstract
14. Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry. 1997;38:102-108. Abstract
15. Das AK, Olfson M, Gameroff MJ, et al. Screening for bipolar disorder in a primary care practice. JAMA. 2005;293:956-963. Abstract
16. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord. 1997;43:163-166. Abstract
17. Hantouche EG, Akiskal HS, Lancrenon S, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord. 1998;50:163-173. Abstract
18. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull. 1987;23:68-73. Abstract
19. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord. 2000;59(suppl 1):S5-S30. Abstract
20. Rybakowski JK, Suwalska A, Lojko D, Rymaszewska J, Kiejna A. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression. J Affect Disord. 2005;84:141-147. Abstract
21. Ghaemi SN, Ko JY, Goodwin FK. The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract. 2001;7:287-297. Abstract
22. Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J Affect Disord. 2005;84:251-257.
23. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385-401.
24. Hirschfeld RMA, Williams JB, Spitzer RL, et al. Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire, Am J Psychiatry. 2000;157: 1873-1875.
25. Hirschfeld RM, Holzer C, Calabrese JR, et al. Validity of the mood disorder questionnaire: a general population study. Am J Psychiatry. 2003;160:178-180. Abstract
26. McLellan AT, Luborsky LL, Woody GE, et al. Predicting response to alcohol and drug abuse treatments. Arch Gen Psychiatry. 1983;620-625.
27. McLellan AT, Luborsky LL, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. J Nerv Mental Disease. 1980;168:26-33.
28. Miller CJ, Klugman J, Berv DA, Rosenquist KJ, Ghaemi SN. Sensitivity and specificity of the Mood Disorder Questionnaire for detecting bipolar disorder. J Affect Disord. 2004;81:167-171. Abstract
29. Mantere O, Suominen K, Leppamaki S, Valtonen H, Arvilommi P, Isometsa E. The clinical characteristics of DSM-IV bipolar I and II disorders: baseline findings from the Jorvi Bipolar Study (JoBS). Bipolar Disord. 2004;6):395-405. Abstract
30. Benazzi F. Bipolar II disorder family history using the family history screen: findings and clinical implications. Compr Psychiatry. 2004;45:77-82. Abstract
31. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63:120-125. Abstract
32. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627. Abstract
33. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004;161:2222-2229. Abstract
34. Calabrese JR, Hirschfeld RM, Reed M, et al. Impact of bipolar disorder on a US community sample. J Clin Psychiatry. 2003;64:425-432. Abstract
35. Angst J. Hypomania. Apropos of a cohort of young patients (French). Encephale. 1992;18(Spec No 1):23-29. Abstract
36. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum. J Affect Disord. 2003;73:39-47. Abstract
37. Goldberg JF, Nassir Ghaemi S. Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression. Bipolar Disord. 2005;7(suppi 5):3-12. Abstract
38. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5:421-433. Abstract
39. Post RM, Leverich GS, Nolen WA, et al; Stanley Foundation Bipolar Network. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003;5:396-406. Abstract
40. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 suppl): 1-50.